Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan's Toray Develops Nasal Insulin Spray For Diabetes

This article was originally published in PharmAsia News

Executive Summary

Japanese pharmaceutical and textile conglomerate Toray has developed a nasal spray technology to deliver insulin to patients with diabetes. The company uses multiple amino acid peptides and mixes them into insulin. Collaborating with Hoshi Medical School, Toray announced that a preclinical animal test has confirmed that over half of the active ingredient entered the blood stream. Toray is looking for partners to commercialize the technology and plans to enter a clinical trial. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072499

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel